Bahrain vs Finland: Prevalence of current tobacco use, males
Prevalence of current tobacco use, males over time
- Bahrain
- Finland
How they compare
Finland currently reports 25.3% against 24.9% in Bahrain, a difference of 0.4%.
Across all 9 years both countries report, Finland has been ahead every year.
Bahrain ranks 95th and Finland ranks 92nd of 166 countries.
Finland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Finland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.4% | 43.4% | 10.0% | Finland |
| 2010s | 29.4% | 34.5% | 5.1% | Finland |
| 2020s | 25.4% | 26.5% | 1.0% | Finland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, males, Bahrain or Finland?
- Finland, at 25.3% against 24.9% in Bahrain as of 2024.
- What is the difference in prevalence of current tobacco use, males between Bahrain and Finland?
- 0.4%, with Finland ahead.
- How many years of comparable data are there for Bahrain and Finland?
- 9 years are reported by both, from 2000 to 2024.
- How do Bahrain and Finland rank globally for prevalence of current tobacco use, males?
- Bahrain ranks 95th and Finland ranks 92nd of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use, males (% of male adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.